Factors Influencing First Anti-Seizure Medication in Adults
This study looked at the first anti-seizure medications (ASMs) prescribed to adults who were newly diagnosed with epilepsy in New York between 2011 and 2019.
This study looked at the first anti-seizure medications (ASMs) prescribed to adults who were newly diagnosed with epilepsy in New York between 2011 and 2019.
This study looked at the risk factors for post-traumatic seizures (PTS) in adults who have experienced traumatic brain injuries (TBI).
This study looked at whether patient-reported outcome measures (PROMs) can help predict the risk of death in adults with various neurological conditions, including epilepsy.
A study was conducted to look at how effective vagus nerve stimulation (VNS) is for treating children with hard-to-control epilepsy, specifically those who have myoclonic seizures.
A recent study looked at how anti-seizure medications (ASMs) are used and their costs for children in France from 2014 to 2023.
This study looked at the effects of highly purified cannabidiol (CBD) on girls with CDKL5 deficiency disorder (CDD), a condition that causes severe seizures and other challenges.
This study looked at a new online tool called EPstat, which provides doctors with real-world data about how well different epilepsy medications work for patients.
Researchers studied how well patients with epilepsy and their caregivers understand Sudden Unexpected Death in Epilepsy (SUDEP), which is a serious risk associated with epilepsy.
This study looked at the risk factors for developing post-stroke epilepsy (PSE) in children who have had a stroke.